Testis cancer affects 2-3 men per every 100,000 in the United States,
making it the most common solid tumor of men in the 20-35-year-old age
range. Since the average age of active duty military personnel is inc
luded in the age range of those at greatest risk for germ cell testis
cancer, it is of pertinent clinical importance to physicians who treat
these young patients. The National Naval Medical Center has been usin
g cisplatin-based protocols since the time of their introduction. This
study reviews the success of treating these patients and examines the
treatment failures. (C) 1996 Wiley-Liss, Inc.